{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:11:03Z","timestamp":1788210663529,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ypmed.2022.107376","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:24:42Z","timestamp":1670293482000},"page":"107376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Long-term effects of the interruption of the Dutch breast cancer screening program due to COVID-19: A modelling study"],"prefix":"10.1016","volume":"166","author":[{"given":"Keris","family":"Poelhekken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel J.W.","family":"Greuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"de Munck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank B.","family":"Brokken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2022.107376_bb0005","article-title":"The impact of the Covid-19 pandemic on breast cancer early detection and screening","author":"Breast Screening Working Group (WG2) of the Covid-19 and Cancer Global Modelling Consortium","year":"2021","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2022.107376_bb0010","series-title":"Simrisc V 14.04.00","author":"Brokken","year":"2021"},{"key":"10.1016\/j.ypmed.2022.107376_bb0015","series-title":"Simulated Impacts of COVID-19 Scenarios on Cancer Screening - Summary Report","author":"Cancer Counsil NSW","year":"2020"},{"key":"10.1016\/j.ypmed.2022.107376_bb0020","article-title":"Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission initiative on breast Cancer (ECIBC)","author":"Canelo-Aybar","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2022.107376_bb0025","series-title":"Factsheet bevolkingsonderzoek borstkanker 2020","author":"Center for Population Screening","year":"2020"},{"key":"10.1016\/j.ypmed.2022.107376_bb0030","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/bjc.2013.149","article-title":"Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness","volume":"108","author":"de Bock","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2022.107376_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/ajco.13505","article-title":"An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic","author":"Degeling","year":"2021","journal-title":"Asia-Pacific J. Clin. Oncol."},{"key":"10.1016\/j.ypmed.2022.107376_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13045-020-00984-1","article-title":"The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands","volume":"13","author":"Dinmohamed","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ypmed.2022.107376_bb0045","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2021203935","article-title":"Beneficial effect of consecutive screening mammography examinations on mortality from breast Cancer: a prospective study","author":"Duffy","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.ypmed.2022.107376_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106602","article-title":"NABON COVID-19 consortium and the COVID and Cancer-NL consortium, \u2018impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic\u2019","volume":"151","author":"Eijkelboom","year":"2021","journal-title":"Prev. Med."},{"issue":"64","key":"10.1016\/j.ypmed.2022.107376_bb0055","article-title":"Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study","volume":"14","author":"Eijkelboom","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.ypmed.2022.107376_bb0060","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.clbc.2020.08.002","article-title":"Effect of the COVID-19 pandemic on surgical breast cancer care in the Netherlands: a multicenter retrospective cohort study","volume":"20","author":"Filipe","year":"2020","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ypmed.2022.107376_bb0065","series-title":"National Evaluation of Breast Cancer Screening in the Netherlands 1990\u20132011\/2012 (XIII)","author":"Fracheboud","year":"2014"},{"issue":"3","key":"10.1016\/j.ypmed.2022.107376_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejca.2009.10.030","article-title":"The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer risk","volume":"46","author":"Greuter","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2022.107376_bb0075","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2022.107376_bb0080","series-title":"Monitor Bevolkingsonderzoek Borstkanker 2020\/2021","author":"IKNL","year":"2021"},{"key":"10.1016\/j.ypmed.2022.107376_bb0085","author":"IKNL"},{"issue":"3","key":"10.1016\/j.ypmed.2022.107376_bb0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/0962280217734583","article-title":"Modelling breast cancer tumour growth for a stable disease population","volume":"28","author":"Isheden","year":"2019","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.ypmed.2022.107376_bb0095","article-title":"A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic","author":"Joung","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2022.107376_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2017.12.009","article-title":"A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening","volume":"109","author":"Koleva-Kolarova","year":"2018","journal-title":"Maturitas"},{"key":"10.1016\/j.ypmed.2022.107376_bb0105","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0959-8049(20)30561-X","article-title":"Effects of cancer screening restart strategies after COVID-19 disruption","volume":"138","author":"Kregting","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2022.107376_bb0110","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","article-title":"Breast-Cancer screening - viewpoint of the IARC working group","volume":"372","author":"Lauby-Secretan","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ypmed.2022.107376_bb0115","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/bjs.8850","article-title":"Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment","volume":"99","author":"Lu","year":"2012","journal-title":"BJS"},{"issue":"12","key":"10.1016\/j.ypmed.2022.107376_bb0120","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.3390\/cancers14123029","article-title":"Prompt resumption of screening Programme reduced the impact of COVID-19 on new breast Cancer diagnoses in northern Italy","volume":"14","author":"Mangone","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.ypmed.2022.107376_bb0125","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study","volume":"21","author":"Maringe","year":"2020","journal-title":"The Lancet Oncol."},{"key":"10.1016\/j.ypmed.2022.107376_bb0130","series-title":"Committee on the Biological Effects of Ionizing Radiation., \u2018Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR VII Phase 2)","author":"National Research Council","year":"2006"},{"key":"10.1016\/j.ypmed.2022.107376_bb0135","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1002\/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C","article-title":"Age-dependent growth rate of primary breast cancer","volume":"71","author":"Peer","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2022.107376_bb0140","author":"RIVM"},{"issue":"2","key":"10.1016\/j.ypmed.2022.107376_bb0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/1055-9965.EPI-17-0378","article-title":"Effect of time to diagnostic testing for breast, cervical, and colorectal Cancer screening abnormalities on screening efficacy: a modelling study","volume":"27","author":"Rutter","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6497","key":"10.1016\/j.ypmed.2022.107376_bb0150","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1126\/science.abd3377","article-title":"COVID-19 and cancer","volume":"368","author":"Sharpless","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ypmed.2022.107376_bb0155","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.21873\/invivo.12139","article-title":"Lockdown of breast cancer screening for COVID-19: possible scenario","volume":"34","author":"Vanni","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.ypmed.2022.107376_bb0160","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1007\/s00330-020-06812-x","article-title":"The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program","volume":"30","author":"Wang","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ypmed.2022.107376_bb0165","article-title":"The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada","author":"Yong","year":"2020","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.ypmed.2022.107376_bb0170","article-title":"Comparison of early- and late-stage breast and colorectal Cancer diagnoses during vs before the COVID-19 pandemic","volume":"2","author":"Zhou","year":"2022","journal-title":"JAMA Netw. Open"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522004418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522004418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:18:30Z","timestamp":1758795510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743522004418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":34,"alternative-id":["S0091743522004418"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107376","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of the interruption of the Dutch breast cancer screening program due to COVID-19: A modelling study","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107376"}}